ALDH1A1 and neoplasm: Importantly, the increased levels of ALDH1 expression and activity in these subpopulations was associated with enhanced tumorigenicity, thus confirming the suitability of this molecule to be used as a CSC marker for sarcomas and also suggesting that ALDH1 could be useful for tracking the malignant potential of CSC subpopulations during tumor evolution and treatment.